Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Interventional
×
DNA Virus Infections
×
Clear all
Filters
3
NCT03487549
2024-11-27
COVE-1
Verrica Pharmaceuticals Inc.
Phase 2
Completed
56 enrolled
29 charts